Founder, Chairman and CEO
Mr. Golden founded the Company in 2000. He has served as either Chairman and CEO or Executive Chairman since inception. Mr. Golden was a co-founder, seed investor and director of Stentor, Inc., a successful life sciences company spun out of the University of Pittsburgh in 1998 and sold to Royal Philips Electronics in 2005. In 1997, Mr. Golden approached UPMC Health System for assistance in starting an SBA-funded venture capital firm to stimulate the development of a life sciences industry cluster in Pittsburgh. The result was Lancet Capital Health Ventures, L.P., the first SBA-licensed venture capital firm affiliated with an academic medical center. Lancet Capital was the seed investor in Noveome; its limited partners include Pittsburgh’s leading healthcare institutions including UPMC Health System, Highmark Blue Cross/Blue Shield, the University of Pittsburgh and Carnegie Mellon University. Mr. Golden is Managing Director of Lancet Capital. Previously, Mr. Golden worked in venture capital at Boston University, corporate finance at Dravo Corp. and Trammell Crow, and management consulting at Arthur D. Little, Inc. Mr. Golden has an M.B.A. from Harvard Business School and a B.S. in Mechanical Engineering from the University of Notre Dame. He is a Chartered Financial Analyst.